|Traded as||NYSE: PBH|
|Industry||Over-The-Counter Healthcare products, and Household Cleaning products|
|Headquarters||Tarrytown, New York, U.S.|
|Revenue||US$ 602.0 million (fiscal 2014)|
|US$ 188.6 million (fiscal 2014)|
|US$ 72.6 million (fiscal 2014)|
Number of employees
Prestige Brands Holdings, Inc. is a company that markets and distributes Over-The-Counter Healthcare and Household Cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and The Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York.
Among the brands owned by Prestige Brands are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC & Goody's Headache Powders, Pediacare & Little Remedies children's OTC products, Beano (dietary supplement), Comet and Spic and Span household cleaning products.
The company's CEO and president is Ron Lombardi, who replaced Mathew Mannelly on 1 June 2015.
Prestige Brands Holdings, inc was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCH Golder Rauner.
The Company acquired Blacksmith Brands' portfolio of 5 brands in 2010.
In 2013, Prestige Brands Holdings, Inc acquired Care Pharmaceuticals of Bondi Junction, New South Wales Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the Company purchased Hydralyte™ in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia & New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In 2012, The Company divested its Phazyme gas treatment brand.
- url=http://ir.prestigebrands.com/phoenix.zhtml?c=182173&p=irol-sec&secCat01.1_rs=11&secCat01.1_rc=10&nn=1&control_selectgroup=0SEC Filings Prestige Brands, Inc.
- "Senior Management Team". Retrieved Jun 14, 2015.
- "MidOcean Partners Agrees to Sell Prestige Brands To GTCH Golder Rauner". News & Press. 12 February 2014.